Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2024. Read More.
Open Access Percentage
48%
Total
Publications
583
Total Open
Publications
279
Total
Citations
44K
Open Access
Percentage
48%
Total
Publications
583
Total Open
Publications
279
Total
Citations
44K
Breakdown
Publisher Open
14%
Both
26%
Other Platform Open
7%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 43%
97
Hybrid 27%
61
No Guarantees 30%
69
Other Platform Open
Domain 87%
168
Institution 19%
37
Other Internet 14%
27
Public 2%
4
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 170 |
DOI | Other Internet | 23 |
Utrecht University - Utrecht University Repository | Institution | 6 |
DANS - Data Archiving and Networked Services | Institution | 6 |
Unknown Repository | Other Internet | 5 |
Europe PMC | Domain | 4 |
DASH - Digital Access to Scholarship at Harvard | Institution | 4 |
Universite de Bordeaux - Oskar-Bordeaux | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
Figshare | Public | 3 |